CAR T Therapy as Cancer Treatment for Patients from West Palm Beach, FL

Moffitt Cancer Center offers CAR T therapy to patients from West Palm Beach, Florida, and throughout the country at our center in Tampa. CAR T therapy is a revolutionary type of immunotherapy that harnesses the body’s natural healing abilities to attack cancer cells. By merging breakthrough treatments like CAR T therapy with individualized attention and compassionate supportive care, Moffitt is able to achieve more positive outcomes and improve quality of life for our patients.

What does CAR T therapy involve?

T cells are part of the body’s immune system. Their purpose is to attack viruses, bacteria and other noncancerous threats to health. During CAR T therapy, the patient’s own T cells are genetically modified with chimeric antigen receptors (CAR) that allow them to recognize a specific protein in cancer cells. Once modified, the T cells seek out and destroy cancer cells while leaving healthy cells unharmed.

Here is a brief overview of the one-time CAR T therapy procedure:

  • A blood sample is taken from the patient.
  • The T cells are separated from other cells in a lab and modified.
  • The patient undergoes a few days of chemotherapy to help prepare the body for new cells.
  • The modified T cells are infused back into the patient.

What types of cancer does CAR T therapy treat?

CAR T therapy is largely used to treat cancers that affect the blood and bone marrow, such as leukemia, lymphoma and multiple myeloma. It has been recognized as a successful treatment for certain patients who have not responded to chemotherapy, radiation therapy and other methods.

Patients from West Palm Beach, FL, who are traveling to Moffitt to receive CAR T therapy or another treatment are invited to take advantage of discounted rates at one of our partner hotels.

If you live in West Palm Beach, FL, and would like to consult a Moffitt physician regarding your cancer treatment options, call 1-888-663-3488 or submit a new patient registration form online.